Quantcast

Latest Lupus erythematosus Stories

2011-07-28 15:38:00

ANAHEIM, Calif., July 28, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Canaccord Genuity Growth Conference to be held August 9-11, 2011 at the InterContinental Boston in Boston, MA. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Thursday, August 11, 2011 at 9:00 a.m. ET. To listen to the audio web cast of the presentation during or after the...

2011-07-12 10:32:00

To view the Social Media Release, click here: http://smr.newswire.ca/en/lupus-canada/first-new-lupus-treatment-in-almost-50-years MARKHAM, ON, July 12, 2011 /PRNewswire/ - Health Canada's recent approval of BENLYSTA(TM) marks the first new treatment available in almost 50 years to the over 1:1000 Canadian men, women and children who are living with Systemic Lupus Erythematosus (SLE) an autoimmune disease with no known cause or cure. Lupus most often affects women of childbearing age...

2011-05-07 00:00:29

Mayor Michael R. Bloomberg this week presented the S.L.E. Lupus Foundation, the patient services and research organization that has served New Yorkers with lupus for over 40 years, with a proclamation declaring May 2011 as "Lupus Awareness Month in New York City." New York, NY (PRWEB) May 06, 2011 Mayor Michael R. Bloomberg this week presented the S.L.E. Lupus Foundation, the patient services and research organization that has served New Yorkers with lupus for over 40 years, with a...

2011-05-06 06:00:00

To view the Social Media Release, click here: http://smr.newswire.ca/en/lupus-canada/take-a-step-to-conquer-lupus MARKHAM, ON, May 6 /PRNewswire/ - In the month of May residents in communities across Canada will participate in Lupus Canada's most important public awareness and fundraising event, Walk for Lupus. Lupus Canada, in partnership with its provincial member organizations, is holding their 10th Annual Walk for Lupus campaign in conjunction with World Lupus Day to help increase...

2011-05-03 16:00:00

HAYWARD, Calif., May 3, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended March 31, 2011. Financial Results: Total operating expenses for the first quarter ended March 31, 2011 were $18.7 million, as compared to $6.5 million for the same period in 2010. The increased operating expenses in the first quarter of 2011 were driven by expenses related to site initiations and the active enrollment...

2011-04-06 13:33:00

AWARDS AN ADDITIONAL $3.6 MILLION IN LUPUS RESEARCH, REACHING $5.6 MILLION IN 2010 NEW YORK, April 6, 2011 /PRNewswire-USNewswire/ -- The Alliance for Lupus Research (ALR) - the world's largest private funder of lupus research - today announced its most recent medical research grant awards, totaling $3.6 million, which support the ALR mission of finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE, or lupus), a debilitating autoimmune disease....

2011-03-23 03:35:24

Results may lead to test to identify women at risk of this pregnancy-related complication Scientists have discovered genetic defects that appear to predispose women to a common pregnancy-related medical problem called preeclampsia that can threaten the life of both baby and mother. Lead investigator Jane Salmon, M.D., a rheumatologist and senior scientist at Hospital for Special Surgery in New York City, and colleagues uncovered genetic mutations in women with the autoimmune diseases...

2011-03-11 00:00:27

The New York City-based S.L.E. Lupus Foundation and its West Coast division Lupus LA welcome the U.S. Food and Drug Administration's (FDA) historic approval of BENLYSTA® (belimumab) for systemic lupus erythematosus (lupus), which is now the first new treatment approved for the chronic autoimmune disease in more than half a century. New York, NY (PRWEB) March 10, 2011 The New York City-based S.L.E. Lupus Foundation and its West Coast division Lupus LA welcome the U.S. Food and Drug...

2011-03-10 14:23:13

The long path to Benlysta emphasizes importance of basic research Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues. "I am deeply gratified that our scientific...

2011-03-09 18:01:00

Lupus Research Institute Welcomes First New Treatment Approved For Lupus in More Than 50 Years NEW YORK, March 9, 2011 /PRNewswire-USNewswire/ -- The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations welcome the U.S. Food and Drug Administration's (FDA) historic approval of BENLYSTA(®) (belimumab) for systemic lupus erythematosus (lupus), launching the first safe and effective treatment for lupus in more than half a century....


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related